The late filing issue has been resolved, removing immediate delisting risk. However, the company's ongoing exploration of strategic alternatives suggests potential M&A, asset sale, or reverse merger. Monitor for announcements regarding strategic transactions or further restructuring.
Price Chart
Executive Summary
Exicure received a Nasdaq non-compliance notice for late filing of its Q1 2026 10-Q, but filed the report on May 29, 2026 and believes it has regained compliance. The company is exploring strategic alternatives after restructuring and suspending clinical activities, with a lead program in stem cell mobilization.
Key Facts
- Nasdaq notified Exicure on May 28, 2026 of non-compliance with Listing Rule 5250(c)(1) due to delayed 10-Q filing.
- The 10-Q for the three months ended March 31, 2026 was filed on May 29, 2026, curing the deficiency.
- Company is exploring strategic alternatives after restructuring and suspension of clinical/development activities.
- Lead program is in stem cell mobilization for multiple myeloma, sickle cell disease, and cell/gene therapy.
Financial Impact
No financial figures disclosed in the press release.
Risk Factors
- Nasdaq could still impose additional listing requirements or penalties despite the cure.
- Strategic alternatives may not result in value realization for shareholders.
- Lead program is early-stage and may not succeed in clinical trials.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3304694 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 16, 2026 5w ago | 8-K | $1.33 $1.15 | ▲ +13.53% | ▲ +16.71% | $1.09 (+18.05%) |
Jun 30, 2026 16w ago | 8-K | $2.08 $1.75 | ▼ −15.87% | ▼ −14.84% | $1.09 (−47.60%) |
Jun 1, 2026 21w ago | Press Release | $3.11 $1.98 | ▼ −36.33% | ▼ −34.77% | $1.09 (−64.95%) |
Jun 1, 2026 21w ago | 8-K | $3.33 $2.08 | ▼ −37.54% | ▼ −36.24% | $1.09 (−67.27%) |
Apr 10, 2026 28w ago | 8-K | $3.85 $3.38 | ▼ −12.16% | ▼ −19.89% | $1.09 (−71.67%) |
Mar 25, 2026 30w ago | Press Release | $4.61 $3.47 | ▲ +24.73% | ▲ +35.39% | $1.09 (+76.36%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers